Exact Mass: 384.3028

Exact Mass Matches: 384.3028

Found 72 metabolites which its exact mass value is equals to given mass value 384.3028, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

8,11,14,17,20,23-hexacosahexaenoic acid

8Z,11Z,14Z,17Z,20Z,23Z-hexacosahexaenoic acid

C26H40O2 (384.3028)


   

N-Palmitoyl Glutamine

3-hydroxy-4-oxo-3-[(trimethylazaniumyl)methyl]tetradec-5-enoate

C21H40N2O4 (384.2988)


N-palmitoyl glutamine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Palmitic acid amide of Glutamine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Palmitoyl Glutamine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Palmitoyl Glutamine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

N-Myristoyl Arginine

5-[(diaminomethylidene)amino]-2-tetradecanamidopentanoic acid

C20H40N4O3 (384.31)


N-myristoyl arginine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Myristic acid amide of Arginine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Myristoyl Arginine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Myristoyl Arginine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

16-Nitroxystearate

[2-(14-carboxytetradecyl)-2-ethyl-4,4-dimethyl-1,3-oxazolidin-3-yl]oxidanyl

C22H42NO4 (384.3114)


   

Calicoferol H

Calicoferol H

C26H40O2 (384.3028)


   

(3beta,22E)-3-Hydroxy-24-norcholesta-5,22-dien-7-one

(3beta,22E)-3-Hydroxy-24-norcholesta-5,22-dien-7-one

C26H40O2 (384.3028)


   

5alpha,6alpha-epoxy-26,27-dinorergosta-7,22(E)-dien-3beta-ol

5alpha,6alpha-epoxy-26,27-dinorergosta-7,22(E)-dien-3beta-ol

C26H40O2 (384.3028)


   
   

ceriferic acid-I methyl ester

ceriferic acid-I methyl ester

C26H40O2 (384.3028)


   

sesqui-CBG|Sesquicannabigerol

sesqui-CBG|Sesquicannabigerol

C26H40O2 (384.3028)


   

9-Hydroxy-cis-12-octadecenoat|isoricinoleic acid

9-Hydroxy-cis-12-octadecenoat|isoricinoleic acid

C22H44O3Si (384.306)


   

ceriferic acid methyl ester

ceriferic acid methyl ester

C26H40O2 (384.3028)


   

raoulic acid methyl ester

raoulic acid methyl ester

C26H40O2 (384.3028)


   

(23E)-3beta-hydroxy-27-norcholesta-5,23-dien-25-one

(23E)-3beta-hydroxy-27-norcholesta-5,23-dien-25-one

C26H40O2 (384.3028)


   
   
   

L-759,633

3-(1,1-dimethylheptyl)-6aR,7,10,10aR-tetrahydro-1-methoxy-6,6,9-trimethyl-6H-dibenzo[b,d]pyran

C26H40O2 (384.3028)


   

26:6(w3)

8Z,11Z,14Z,17Z,20Z,23Z-hexacosahexaenoic acid

C26H40O2 (384.3028)


   

N-palmitoyl glutamine

N-hexadecanoyl-glutamine

C21H40N2O4 (384.2988)


   

26:6n3

8Z,11Z,14Z,17Z,20Z,23Z-hexacosahexaenoic acid

C26H40O2 (384.3028)


   

DICYCLOHEXYLAMINE (R)-3-((TERT-BUTOXYCARBONYL)AMINO)-2-METHYLPROPANOATE

DICYCLOHEXYLAMINE (R)-3-((TERT-BUTOXYCARBONYL)AMINO)-2-METHYLPROPANOATE

C21H40N2O4 (384.2988)


   

Boc-D-Abu-OH.DCHA

Boc-D-Abu-OH.DCHA

C21H40N2O4 (384.2988)


   

[2-(5-Carboxypentyl)-4,4-dimethyl-2-undecyl-1,3-oxazolidin-3-yl]o xidanyl

[2-(5-Carboxypentyl)-4,4-dimethyl-2-undecyl-1,3-oxazolidin-3-yl]o xidanyl

C22H42NO4 (384.3114)


   

5-Doxyl stearic acid

5-DOXYL-stearic acid, free radical

C22H42NO4 (384.3114)


   

12-Doxyl Stearic Acid

12-Doxyl Stearic Acid

C22H42NO4 (384.3114)


   

[4-(4-propylcyclohexyl)phenyl] 4-butylcyclohexane-1-carboxylate

[4-(4-propylcyclohexyl)phenyl] 4-butylcyclohexane-1-carboxylate

C26H40O2 (384.3028)


   

[3-carboxy-2-[(E)-pentadec-9-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-pentadec-9-enoyl]oxypropyl]-trimethylazanium

C22H42NO4+ (384.3114)


   

4-(4,4-Dimethyl-3-oxido-2-tridecyl-1,3-oxazolidin-2-yl)butanoic acid

4-(4,4-Dimethyl-3-oxido-2-tridecyl-1,3-oxazolidin-2-yl)butanoic acid

C22H42NO4- (384.3114)


   

[3-carboxy-2-[(E)-pentadec-10-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-pentadec-10-enoyl]oxypropyl]-trimethylazanium

C22H42NO4+ (384.3114)


   

[3-carboxy-2-[(E)-pentadec-2-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-pentadec-2-enoyl]oxypropyl]-trimethylazanium

C22H42NO4+ (384.3114)


   

[3-carboxy-2-[(E)-pentadec-7-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-pentadec-7-enoyl]oxypropyl]-trimethylazanium

C22H42NO4+ (384.3114)


   

[3-carboxy-2-[(E)-pentadec-6-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-pentadec-6-enoyl]oxypropyl]-trimethylazanium

C22H42NO4+ (384.3114)


   

[3-carboxy-2-[(E)-pentadec-5-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-pentadec-5-enoyl]oxypropyl]-trimethylazanium

C22H42NO4+ (384.3114)


   

(6aR,10aR)-1-methoxy-6,6,9-trimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene

(6aR,10aR)-1-methoxy-6,6,9-trimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene

C26H40O2 (384.3028)


   

Sesquicannabigerol

Sesquicannabigerol

C26H40O2 (384.3028)


A natural product found in Cannabis sativa.

   

8Z,11Z,14Z,17Z,20Z,23Z-hexacosahexaenoic acid

(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosahexaenoic acid

C26H40O2 (384.3028)


A very long-chain omega-3 fatty acid that is hexacosanoic acid having six double bonds located at positions 8, 11, 14, 17, 20, 23 (the 8Z,11Z,14Z,17Z,20Z,23Z-isomer).

   

16-Nitroxystearate

16-doxyl-stearic acid

C22H42NO4 (384.3114)


   

Hexacosahexaenoic acid

Hexacosahexaenoic acid

C26H40O2 (384.3028)


   

NA-Arg 15:0

NA-Arg 15:0

C20H40N4O3 (384.31)


   
   
   
   

3-{7,7,12,16-tetramethyl-6-oxopentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl}butanal

3-{7,7,12,16-tetramethyl-6-oxopentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl}butanal

C26H40O2 (384.3028)


   

(1r,3as,3bs,9ar,9bs,11ar)-1-[(2r,3e)-5-hydroxy-5-methylhex-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

(1r,3as,3bs,9ar,9bs,11ar)-1-[(2r,3e)-5-hydroxy-5-methylhex-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C26H40O2 (384.3028)


   

methyl 2-[(1s,4s,6r,10r,12r)-1-methyl-6-(3-methylbut-2-en-1-yl)-7-methylidene-12-(prop-1-en-2-yl)bicyclo[8.2.0]dodecan-4-yl]prop-2-enoate

methyl 2-[(1s,4s,6r,10r,12r)-1-methyl-6-(3-methylbut-2-en-1-yl)-7-methylidene-12-(prop-1-en-2-yl)bicyclo[8.2.0]dodecan-4-yl]prop-2-enoate

C26H40O2 (384.3028)


   

methyl (1e,4r,7e,11e)-7,11-dimethyl-4-[(2e)-6-methylhepta-2,5-dien-2-yl]cyclotetradeca-1,7,11-triene-1-carboxylate

methyl (1e,4r,7e,11e)-7,11-dimethyl-4-[(2e)-6-methylhepta-2,5-dien-2-yl]cyclotetradeca-1,7,11-triene-1-carboxylate

C26H40O2 (384.3028)


   

1,2-dimethyl-4-(12-phenyldodecyl)cyclohexa-3,5-diene-1,2-diol

1,2-dimethyl-4-(12-phenyldodecyl)cyclohexa-3,5-diene-1,2-diol

C26H40O2 (384.3028)


   

6-{7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}hept-3-en-2-one

6-{7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}hept-3-en-2-one

C26H40O2 (384.3028)


   

1,2-dimethyl-5-(12-phenyldodecyl)cyclohexa-3,5-diene-1,3-diol

1,2-dimethyl-5-(12-phenyldodecyl)cyclohexa-3,5-diene-1,3-diol

C26H40O2 (384.3028)


   

(1r,3as,4s,5r,7ar)-4-[2-(5-hydroxy-2-methylphenyl)ethyl]-7a-methyl-1-[(2s,3e)-5-methylhex-3-en-2-yl]-octahydroinden-5-ol

(1r,3as,4s,5r,7ar)-4-[2-(5-hydroxy-2-methylphenyl)ethyl]-7a-methyl-1-[(2s,3e)-5-methylhex-3-en-2-yl]-octahydroinden-5-ol

C26H40O2 (384.3028)


   

9a,11a-dimethyl-1-(5-methylhexan-2-yl)-1h,2h,3h,3ah,3bh,6h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-4,7-dione

9a,11a-dimethyl-1-(5-methylhexan-2-yl)-1h,2h,3h,3ah,3bh,6h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-4,7-dione

C26H40O2 (384.3028)


   

methyl 5,11-dimethyl-8-(6-methylhepta-1,5-dien-2-yl)cyclotetradeca-1,5,11-triene-1-carboxylate

methyl 5,11-dimethyl-8-(6-methylhepta-1,5-dien-2-yl)cyclotetradeca-1,5,11-triene-1-carboxylate

C26H40O2 (384.3028)


   

(1r,3as,3bs,7s,9ar,9bs,11ar)-7-hydroxy-9a,11a-dimethyl-1-[(2r,3e)-5-methylhex-3-en-2-yl]-1h,2h,3h,3ah,3bh,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-4-one

(1r,3as,3bs,7s,9ar,9bs,11ar)-7-hydroxy-9a,11a-dimethyl-1-[(2r,3e)-5-methylhex-3-en-2-yl]-1h,2h,3h,3ah,3bh,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-4-one

C26H40O2 (384.3028)


   

(6r)-6-[(1r,3as,3bs,7s,9ar,9bs,11ar)-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]hept-1-en-3-one

(6r)-6-[(1r,3as,3bs,7s,9ar,9bs,11ar)-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]hept-1-en-3-one

C26H40O2 (384.3028)


   

methyl 7,11-dimethyl-4-(6-methylhepta-1,5-dien-2-yl)cyclotetradeca-1,7,11-triene-1-carboxylate

methyl 7,11-dimethyl-4-(6-methylhepta-1,5-dien-2-yl)cyclotetradeca-1,7,11-triene-1-carboxylate

C26H40O2 (384.3028)


   

methyl 7,11-dimethyl-4-(6-methylhepta-2,5-dien-2-yl)cyclotetradeca-1,7,11-triene-1-carboxylate

methyl 7,11-dimethyl-4-(6-methylhepta-2,5-dien-2-yl)cyclotetradeca-1,7,11-triene-1-carboxylate

C26H40O2 (384.3028)


   

2,16-dimethyl-15-(5-methylhex-3-en-2-yl)-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-10-en-5-ol

2,16-dimethyl-15-(5-methylhex-3-en-2-yl)-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-10-en-5-ol

C26H40O2 (384.3028)


   

(1r,3as,3bs,9ar,9bs,11ar)-9a,11a-dimethyl-1-[(2r)-5-methylhexan-2-yl]-1h,2h,3h,3ah,3bh,6h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-4,7-dione

(1r,3as,3bs,9ar,9bs,11ar)-9a,11a-dimethyl-1-[(2r)-5-methylhexan-2-yl]-1h,2h,3h,3ah,3bh,6h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-4,7-dione

C26H40O2 (384.3028)


   

methyl (1e,4r,7e,11e)-7,11-dimethyl-4-(6-methylhepta-1,5-dien-2-yl)cyclotetradeca-1,7,11-triene-1-carboxylate

methyl (1e,4r,7e,11e)-7,11-dimethyl-4-(6-methylhepta-1,5-dien-2-yl)cyclotetradeca-1,7,11-triene-1-carboxylate

C26H40O2 (384.3028)


   

6-{7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}hept-1-en-3-one

6-{7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}hept-1-en-3-one

C26H40O2 (384.3028)


   

7-hydroxy-9a,11a-dimethyl-1-(5-methylhex-3-en-2-yl)-1h,2h,3h,3ah,3bh,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-4-one

7-hydroxy-9a,11a-dimethyl-1-(5-methylhex-3-en-2-yl)-1h,2h,3h,3ah,3bh,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-4-one

C26H40O2 (384.3028)


   

(1s,2r,5s,7r,9s,12r,15r,16r)-2,16-dimethyl-15-[(2r,3e)-5-methylhex-3-en-2-yl]-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-10-en-5-ol

(1s,2r,5s,7r,9s,12r,15r,16r)-2,16-dimethyl-15-[(2r,3e)-5-methylhex-3-en-2-yl]-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-10-en-5-ol

C26H40O2 (384.3028)


   

1-(5-hydroxy-5-methylhex-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

1-(5-hydroxy-5-methylhex-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C26H40O2 (384.3028)


   

methyl 5,9-dimethyl-12-(6-methylhepta-1,5-dien-2-yl)cyclotetradeca-1,5,9-triene-1-carboxylate

methyl 5,9-dimethyl-12-(6-methylhepta-1,5-dien-2-yl)cyclotetradeca-1,5,9-triene-1-carboxylate

C26H40O2 (384.3028)


   

(1r,3as,4s,5r,7ar)-4-[2-(5-hydroxy-2-methylphenyl)ethyl]-7a-methyl-1-[(2r,3e)-5-methylhex-3-en-2-yl]-octahydroinden-5-ol

(1r,3as,4s,5r,7ar)-4-[2-(5-hydroxy-2-methylphenyl)ethyl]-7a-methyl-1-[(2r,3e)-5-methylhex-3-en-2-yl]-octahydroinden-5-ol

C26H40O2 (384.3028)


   

(3e,6r)-6-[(1r,3as,3bs,7s,9ar,9bs,11ar)-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]hept-3-en-2-one

(3e,6r)-6-[(1r,3as,3bs,7s,9ar,9bs,11ar)-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]hept-3-en-2-one

C26H40O2 (384.3028)


   

(3r)-3-[(1s,3r,8r,11s,12s,15r,16r)-7,7,12,16-tetramethyl-6-oxopentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl]butanal

(3r)-3-[(1s,3r,8r,11s,12s,15r,16r)-7,7,12,16-tetramethyl-6-oxopentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl]butanal

C26H40O2 (384.3028)


   

methyl (1e,5z,9e,12r)-5,9-dimethyl-12-(6-methylhepta-1,5-dien-2-yl)cyclotetradeca-1,5,9-triene-1-carboxylate

methyl (1e,5z,9e,12r)-5,9-dimethyl-12-(6-methylhepta-1,5-dien-2-yl)cyclotetradeca-1,5,9-triene-1-carboxylate

C26H40O2 (384.3028)


   

5-pentyl-2-(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)benzene-1,3-diol

5-pentyl-2-(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)benzene-1,3-diol

C26H40O2 (384.3028)


   

methyl (1z,5e,8r,11e)-5,11-dimethyl-8-(6-methylhepta-1,5-dien-2-yl)cyclotetradeca-1,5,11-triene-1-carboxylate

methyl (1z,5e,8r,11e)-5,11-dimethyl-8-(6-methylhepta-1,5-dien-2-yl)cyclotetradeca-1,5,11-triene-1-carboxylate

C26H40O2 (384.3028)


   

methyl 2-[1-methyl-6-(3-methylbut-2-en-1-yl)-7-methylidene-12-(prop-1-en-2-yl)bicyclo[8.2.0]dodecan-4-yl]prop-2-enoate

methyl 2-[1-methyl-6-(3-methylbut-2-en-1-yl)-7-methylidene-12-(prop-1-en-2-yl)bicyclo[8.2.0]dodecan-4-yl]prop-2-enoate

C26H40O2 (384.3028)